Reports for GE HEALTHCARE CANADA INC

Company Name

GE HEALTHCARE CANADA INC

Totals

Shortage reports

79

Actual shortage: 2 (3%)
Anticipated shortage: 0 (0%)
Avoided shortage: 6 (8%)
Resolved: 71 (90%)

Discontinuation Reports

5

To be discontinued: 0 (0%)
Discontinued: 5 (100%)
Reversed: 0 (0%)

Late reports

0 (0%)

Overdue reports

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TECHNETIUM TC 99M TSC 2MG POWDER FOR SOLUTION KIT SOLUTION Resolved 2022-02-07 2022-02-11 154319
TECHNETIUM TC 99M TSC 2MG POWDER FOR SOLUTION KIT SOLUTION Resolved 2022-03-10 2022-11-07 156500
TECHNETIUM TC 99M TSC 2MG POWDER FOR SOLUTION KIT SOLUTION Resolved 2022-06-29 2022-08-27 163670
TECHNETIUM TC 99M TSC 2MG POWDER FOR SOLUTION KIT SOLUTION Actual shortage 2024-01-17 2024-02-09 216303
CERETEC 0.5MG POWDER FOR SOLUTION KIT Resolved 2021-08-05 2021-09-09 143671
CERETEC 0.5MG POWDER FOR SOLUTION KIT Resolved 2021-12-14 2022-01-01 151119
CERETEC 0.5MG POWDER FOR SOLUTION KIT Resolved 2022-05-06 2022-05-12 160149
Technetium Tc 99m TSC not applicable Reaction vial - lyophilized form; Components - Solution A and Solution B Resolved 2017-06-27 2017-07-06 14093
TECHNETIUM TC 99M TSC 2MG SOLUTION KIT POWDER FOR SOLUTION Resolved 2020-11-03 2020-11-05 127701
VISIPAQUE 270 550MG SOLUTION Resolved 2021-09-03 2021-09-09 145158
VISIPAQUE 270 550MG SOLUTION Resolved 2022-05-13 2023-01-05 160506
VISIPAQUE 270 550MG SOLUTION Resolved 2022-05-27 2023-01-05 161439
VISIPAQUE 270 550MG SOLUTION Resolved 2022-05-27 2023-01-30 161445
VISIPAQUE 270 550MG SOLUTION Resolved 2022-06-03 2023-02-07 161852
VISIPAQUE 320 652MG SOLUTION Resolved 2021-07-30 2021-08-21 143297
VISIPAQUE 320 652MG SOLUTION Resolved 2021-08-18 2021-08-21 144296
VISIPAQUE 320 652MG SOLUTION Resolved 2022-05-13 2023-01-05 160510
VISIPAQUE 320 652MG SOLUTION Resolved 2022-05-13 2023-01-05 160513
VISIPAQUE 320 652MG SOLUTION Resolved 2022-05-13 2023-01-05 160516
VISIPAQUE 320 652MG SOLUTION Resolved 2022-05-13 2023-01-31 160519

Showing 1 to 20 of 79

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
OMNIPAQUE 180 388MG SOLUTION Discontinued 2023-01-31 2023-02-22 182757
OMNIPAQUE 240 518MG SOLUTION Discontinued 2023-01-31 2023-03-18 182760
OMNISCAN 287MG SOLUTION Discontinued 2023-01-31 2023-03-25 182742
Metastron 37 MBq/mL Solution Discontinued 2018-10-12 2019-02-01 63929
THALLOUS CHLORIDE TI 201 INJECTION 37MBq SOLUTION Discontinued 2020-12-04 2021-06-05 129592

Showing 1 to 5 of 5